Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 19, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 18, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Eddie Hickman Initiated (TARS) at Strong Buy on, May 18th, 2023
Eddie Hickman of Guggenheim, Initiated "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy on, May 18th, 2023.
Eddie has made no other calls on TARS in the last 4 months.
There are 2 other peers that have a rating on TARS. Out of the 2 peers that are also analyzing TARS, 0 agree with Eddie's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Eddie
- Francois Brisebois of "Oppenheimer" Reiterated at Buy and Held Target at $43 on, Monday, May 8th, 2023
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Wednesday, March 15th, 2023
